scholarly article | Q13442814 |
P50 | author | John Leung | Q86656324 |
P2093 | author name string | Alice Hangzhou Shen | |
Koen Robert Beukema | |||
P2860 | cites work | Identification of human CCR8 as a CCL18 receptor | Q24618546 |
An etiological role for aeroallergens and eosinophils in experimental esophagitis | Q24682860 | ||
Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis | Q28080597 | ||
Intestinal barrier function: molecular regulation and disease pathogenesis | Q28250081 | ||
Common variants at 5q22 associate with pediatric eosinophilic esophagitis | Q28943383 | ||
Determinants of food allergy | Q30422603 | ||
Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection | Q30633072 | ||
Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis | Q33346591 | ||
Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. | Q33975785 | ||
Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 | ||
Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice | Q34015413 | ||
Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy | Q34045448 | ||
Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis | Q34166618 | ||
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers | Q34258717 | ||
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis | Q34331377 | ||
TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis | Q34506122 | ||
Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis | Q34511599 | ||
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro | Q34563241 | ||
Molecular, genetic, and cellular bases for treating eosinophilic esophagitis | Q35537424 | ||
Esophageal microbiome in eosinophilic esophagitis. | Q35644767 | ||
TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation | Q35686590 | ||
Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis | Q35900865 | ||
The 'microflora hypothesis' of allergic diseases | Q36360555 | ||
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses | Q36446865 | ||
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. | Q36553408 | ||
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia | Q37124757 | ||
Oral tolerance, food allergy, and immunotherapy: implications for future treatment | Q37138202 | ||
Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting | Q37218675 | ||
Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis | Q37448788 | ||
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. | Q37468363 | ||
Haemopoietic processes in allergic disease: eosinophil/basophil development | Q37557714 | ||
Invariant natural killer T cells in children with eosinophilic esophagitis. | Q37588544 | ||
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. | Q37632813 | ||
Food allergy: Insights into etiology, prevention, and treatment provided by murine models. | Q37648318 | ||
Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses | Q37678487 | ||
Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis | Q37693833 | ||
The immunology of food allergy | Q37705589 | ||
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). | Q38097271 | ||
Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis | Q38248758 | ||
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? | Q38260970 | ||
Innate lymphoid cells in type 2 immune responses | Q38295077 | ||
A striking local esophageal cytokine expression profile in eosinophilic esophagitis. | Q38338212 | ||
Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. | Q38959847 | ||
Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus | Q38975895 | ||
Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis | Q39600165 | ||
Marked eosinophilia in esophageal mucosal biopsies | Q39865636 | ||
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. | Q40036792 | ||
Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans | Q40527755 | ||
Eosinophilic gastroenteritis with esophageal involvement. | Q40882306 | ||
Pathogenic role of mast cells in experimental eosinophilic esophagitis | Q41911416 | ||
Periostin promotes chronic allergic inflammation in response to Th2 cytokines. | Q41926592 | ||
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses | Q42060778 | ||
Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. | Q42468693 | ||
Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. | Q42935186 | ||
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. | Q42972510 | ||
Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis | Q43585214 | ||
Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate | Q43976603 | ||
Basophils express a type 2 cytokine profile on exposure to proteases from helminths and house dust mites | Q44276703 | ||
Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents | Q44434993 | ||
Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism | Q44642524 | ||
Antigen presentation by eosinophils in eosinophilic esophagitis? | Q45166796 | ||
Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. | Q45811536 | ||
Early life exposures as risk factors for pediatric eosinophilic esophagitis. | Q46029307 | ||
Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material | Q46201214 | ||
Esophageal remodeling in pediatric eosinophilic esophagitis | Q46304660 | ||
Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. | Q46638441 | ||
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction | Q46969232 | ||
Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice | Q47733530 | ||
Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis. | Q48230299 | ||
Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors | Q48473259 | ||
Eosinophils: biological properties and role in health and disease. | Q51960619 | ||
Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. | Q53026962 | ||
Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. | Q53649810 | ||
IL-5 promotes eosinophil trafficking to the esophagus. | Q53978537 | ||
Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. | Q54581203 | ||
Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. | Q54624920 | ||
Food allergy: a practice parameter update-2014. | Q55058508 | ||
Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria | Q57339886 | ||
Relative lack of T regulatory cells in adult eosinophilic esophagitis - no normalization after corticosteroid therapy | Q61959734 | ||
Eosinophilic esophagitis in a patient with vigorous achalasia | Q67326956 | ||
Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome | Q70530791 | ||
Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula | Q71737350 | ||
IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression | Q73016780 | ||
A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation | Q73688355 | ||
Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice | Q79460200 | ||
Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus | Q80110762 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 709-720 | |
P577 | publication date | 2015-09-11 | |
P1433 | published in | Best Practice and Research: Clinical Gastroenterology | Q15754316 |
P1476 | title | Allergic mechanisms of Eosinophilic oesophagitis | |
P478 | volume | 29 |
Q90082204 | Chinese medicine Yu-Ping-Feng-San attenuates allergic inflammation by regulating epithelial derived pro-allergic cytokines |
Q92989374 | Cow's Milk Allergy: Immunomodulation by Dietary Intervention |
Q55020153 | Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). |
Q30244585 | Eosinophilic esophagitis in an octogenarian: A case report and review of the literature |
Q37579218 | Establishing the prevalence of low vitamin D in non-immunoglobulin-E mediated gastrointestinal food allergic children in a tertiary centre |
Q38660542 | Incidence of eosinophilic esophagitis in the Netherlands continues to rise: 20-year results from a nationwide pathology database |
Q38828893 | Protease-activated receptor-2 suppresses interleukin (IL)-10 expression in B cells via upregulating Bcl2L12 in patients with allergic rhinitis |
Q90387813 | The Role of the Environment in Eosinophilic Esophagitis |
Search more.